For information on CSL Behring COVID-19 updates, please click here
hero-long-lasting-bleed-protection-for-the-hero-within

For adults and children with hemophilia B LONG-LASTING
BLEED PROTECTION
FOR THE HERO WITHIN

#1 FACTOR IX MOST PRESCRIBED FOR PROPHYLAXIS*

   ONLY IDELVION DELIVERS  

Zero spontaneous bleeds

Whether dosed every 7 or 14 days in pivotal trials

plus
UP TO 14-DAY DOSING. FDA APPROVED

Dosing schedules that fit your lifestyle

plus
20% STEADY-STATE TROUGH LEVELS WITH 7-DAY PROPHYLACTIC USE

High and sustained steady-state FIX levels

*Hemophilia FIX Market Assessment. Third-Party Market Research.

†Zero median annualized spontaneous bleeding rate when dosed at 7 or 14 days in clinical trials.

‡Once well controlled (1 month without spontaneous bleeding or requiring dose adjustments on a weekly dose of ≤40 IU/kg), people 12 years and older can be transitioned to 14-day dosing.

§The average dose for people receiving prophylaxis every 7 days was 37 IU/kg.

Join Us For A Free Interactive Event

Connect and learn more about living with and managing hemophilia B​

Common Connections an IDELVION Story Logo

Michael on what IDELVION dosing means to him

“IDELVION extended dosing means I’ll have more time to study and hang out with friends at college.

SEE MORE REAL-LIFE STORIES

Support you can count on

IDELVION offers a wide variety of resources
to help people with hemophilia B.

X
You are now leaving the current website.

Do you want to continue?